Cipla's Pithampur unit gets 8 observations from US FDA after inspection

Cipla's Pithampur unit gets 8 observations from US FDA after inspection ​​ The US Food and Drug Administration (USFDA) conducted a current Good Manufacturing Practices (cGMP) inspection at the manufacturing facility from February 6 - 17, the Mumbai-based drug firm said in a regulatory filing. On conclusion of the inspection, the company has received 8 inspectional observations in Form 483. https://ift.tt/K7I2UFi